Sunesis Pharma drug voreloxin research report published
SunESIS Pharma in cancer chemotherapy and medicine journals published the latest voreloxin non-clinical studies. The results show that, when used alone, to human acute leukemia cells voreloxin potential cytotoxic effect, if mixed with cytarabine, reinforced or combined action is generated.
Sunesis Pharma drug voreloxin research report published
ReplyDeleteSunESIS Pharma in cancer chemotherapy and medicine journals published the latest voreloxin non-clinical studies. The results show that, when used alone, to human acute leukemia cells voreloxin potential cytotoxic effect, if mixed with cytarabine, reinforced or combined action is generated.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
U0126
AS703026
BIX02188
BIX02189
AZD8330
PD318088
BMS 777607
MEK inhibitor
GDC-0973
CI-1040